A 35-year-old man with a 10-year history of schizophrenia has failed adequate trials of risperidone (6 mg/day × 8 weeks) and olanzapine (15 mg/day × 8 weeks) with persistent positive symptoms (hallucinations, delusions). He has no history of seizures or cardiac arrhythmias. What is the drug of choice for treatment-resistant schizophrenia?

Explanation

## Treatment-Resistant Schizophrenia: Clozapine as Gold Standard **Key Point:** Clozapine is the only antipsychotic with proven efficacy in treatment-resistant schizophrenia (TRS) and is the gold standard for patients who fail ≥2 adequate trials of different antipsychotics at therapeutic doses and durations. ### Definition of Treatment-Resistant Schizophrenia Failure to achieve adequate response (≥20% reduction in positive symptoms) despite: 1. Two or more adequate antipsychotic trials (therapeutic dose for ≥4–8 weeks each) 2. Different pharmacological classes preferred 3. Documented poor adherence excluded ### Why Clozapine in TRS? **Efficacy:** - 30–50% of TRS patients respond to clozapine (vs. <10% to other agents) - Unique mechanism: D2 partial agonism + D1 antagonism + serotonergic modulation - Effective against both positive and negative symptoms - Reduces suicidality and aggression in schizophrenia **Mechanism of Superior Efficacy:** - Rapid dissociation from D2 receptors ("hit-and-run" hypothesis) - Preferential limbic > striatal dopamine blockade - Glutamatergic and GABAergic effects ### Monitoring Requirements for Clozapine | Parameter | Baseline | Frequency | Action | |-----------|----------|-----------|--------| | **WBC/ANC** | Required | Weekly × 6 mo, then biweekly | Stop if ANC <1500 | | **ECG** | Required | If symptoms warrant | Exclude QTc >500 ms | | **Metabolic panel** | Required | Quarterly | Monitor glucose, lipids | | **Seizure threshold** | Assess | Observe clinically | Risk increases at >600 mg/day | **High-Yield:** Clozapine-induced agranulocytosis occurs in ~0.8–1% of patients (highest in first 3 months). Regular WBC monitoring is mandatory and non-negotiable. Myocarditis (rare but serious) can occur within first 2 weeks. **Warning:** Common misconceptions: - ~~Clozapine is contraindicated in all cardiac disease~~ → Only uncontrolled arrhythmias/active myocarditis are absolute contraindications - ~~Clozapine causes seizures in all patients~~ → Dose-dependent risk; manageable with anticonvulsants if needed - ~~Clozapine is first-line~~ → Reserved for TRS only due to toxicity profile **Clinical Pearl:** Clozapine is the only antipsychotic with anti-suicidal efficacy in schizophrenia, making it particularly valuable in high-risk TRS patients. **Tip:** In NEET PG, if the stem explicitly states "failed ≥2 antipsychotic trials" or "treatment-resistant," the answer is clozapine unless contraindicated (active myocarditis, WBC <3500, uncontrolled seizures).